domingo, 26 de julio de 2020

What You Need to Know About the 6 EHE Indicators: The AHEAD Dashboard | HIV.gov

What You Need to Know About the 6 EHE Indicators: The AHEAD Dashboard | HIV.gov

We're getting AHEAD of HIV.

Federal Response Blog Posts
What You Need to Know About the 6 EHE Indicators: The AHEAD Dashboard
HHS’s upcoming Ending the HIV Epidemic (EHE) dashboard, AHEAD, will display data on the six EHE indicators that the federal government uses to track progress towards ending the HIV epidemic in America. These indicators were chosen to create a common understanding for use in comparison, analytics, and future planning. EHE jurisdictions are encouraged to review these definitions.
LEARN MORE
 
Highlights: HIV Research Wrap-Up from AIDS 2020
Last week HIV.gov covered new HIV research coming out of the 23rd International AIDS Conference (AIDS 2020: Virtual), sharing three video interviews about the latest scientific developments with Carl Dieffenbach, Ph.D., director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases. For readers’ convenience, we’ve summarized the coverage so you can catch up on any of the posts or video interviews that you may have missed and share them with your colleagues.
LEARN MORE
 
FDA Approves New HIV Treatment for Patients With Limited Treatment Options
[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
LEARN MORE

No hay comentarios: